Moneycontrol PRO

HomeNewsMnc pharma cos

Mnc Pharma Cos

Jump to

Budget 2023: Foreign pharma firms push for fast-tracking of new drug approvals, ease of doing business

Multinational drugmakers are seeking relaxation of norms that govern the launch of new medicines and clinical trials of drugs in India.
Merck drops India from Priority market list

US pharma major Merck (MSD) dropped India from its list of priority markets. Other top multinational pharma companies have also sounded warning bells about India's IPR regime.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347